The Patent Finder

Janus Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Janus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Janus Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,358,944Methods and compositions for treating generalized anxiety disorder
Formerly held
Term ended
Term ended Aug 23, 2020 · USPTO record
Term endedTerm ended Aug 23, 2020USPTO record
US 6,395,788Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine
Term ended
Term ended Aug 11, 2020 · USPTO record
Term endedTerm ended Aug 11, 2020USPTO record
US 6,080,736Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam
Formerly held
Term ended
Term ended Oct 27, 2019 · USPTO record
Term endedTerm ended Oct 27, 2019USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited